Diffusion Pharmaceuticals Inc

NASDAQ:DFFN  
0.54
0.00 (+0.33%)
Other Pre-Announcement

Diffusion Says Co Has Sufficient Cash Resources To Fund Planned Trials Through 2023

Published: 09/09/2021 11:44 GMT
Diffusion Pharmaceuticals Inc (DFFN) - Diffusion Pharmaceuticals Issues Letter to Shareholders.
Diffusion Pharmaceuticals - Have Sufficient Cash Resources to Fund Planned Clinical Trials and Other Operational Needs Through 2023.